click the video for more on Dr. Jane Cooke Wright
From MBB Yale
In the mid-20th century, using drugs to treat cancer was pretty experimental, so chemotherapy was only used as a last resort for cancer patients. Despite the hesitation towards chemotherapy at the time, Dr. Jane Wright, along with her father [Dr. Louis Wright], focused their research on anti-cancer chemicals. In 1949, the two started testing new chemicals for effective anti-cancer properties on human leukemias and other cancers. This research led to Dr. Jane Cooke’s seminal work in 1951 which established the efficacy of methotrexate in treating breast cancer. This research laid the foundations for treating tumors with chemotherapy.
Dr. Jane Wright was determined to make sure her research had an impact in clinical care. To help bridge the gap between hers and others’ research with clinical care, she became one of the founding members of the American Society of Clinical Oncology (ASCO). She was also the only woman in the founding group. The ASCO has the goal to set standards for clinical oncology and to improve knowledge of the field by making research and information readily available and easily disseminated.
No comments:
Post a Comment